Structure Therapeutics Inc. reports results for the quarter ended September 30 - Earnings Summary

• Structure Therapeutics Inc. reported a quarterly adjusted loss of $1.98​​ per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of $-1.11. The mean expectation of fifteen analysts for the quarter was for a loss of 58 cents per share. Wall Street expected results to range from $-1.37 to -36 cents per share.

• Reported revenue was zero​; analysts expected zero.

• Structure Therapeutics Inc.'s reported EPS for the quarter was a loss of $1.98​.

• The company reported a quarterly loss of $144.76 million.

• Structure Therapeutics Inc. shares had fallen by 30.5% this quarter and lost 68.8% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 14.2% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 16 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for Structure Therapeutics Inc. is $100.00, about 78.3% above its last closing price of $21.73

This summary was machine generated from LSEG data November 11 at 10:00 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)